- Location
medication errors
"-
Schreiner MediPharm to Present New Flexi-Cap at InnoPack
Sep 18, 2015Schreiner MediPharm is to present its new Flexi-Cap at InnoPack which protects containers against tampering and avoid medication errors. The new label and cap combination solution Flexi-Cap is said to prevent the illegal reuse and ...
-
SurgiChem Is a Provider of Medication Adherence Packaging to The UK Care Home
Aug 27, 2014A wholly-owned subsidiary of Bupa Care Homes, Stockport-based SurgiChem is a provider of medication adherence packaging to the UK care home and domiciliary care markets. The company supplies monitored dosage systems to a network of over ...
Tags: SurgiChem, US Firm Omnicell, Packaging
-
Omnicell Has Completed The Acquisition of UK-Based Surgichem
Aug 27, 2014Omnicell has completed the acquisition of UK-based SurgiChem, a wholly-owned subsidiary of Bupa Care Homes (CFG), following approval from the Competition and Markets Authority (CMA) in the UK. CFG will now be integrated with Omnicell's ...
Tags: Omnicell, Acquisition, Packaging
-
NYSE: WAG Opened a Unique Walgreens Store Today on The UCSF Campus
Feb 27, 2014UC San Francisco and Walgreens (NYSE: WAG) (Nasdaq: WAG) have opened a unique Walgreens store today on the UCSF campus that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively by ...
-
Drug Shortages Remain a Serious Problem for Patient Safety
Jan 14, 2014According to newly published results from a survey of pharmacy directors, drug shortages remain a serious problem for patient safety. Nearly half of the responding directors reported adverse events at their facilities due to drug shortages, ...
Tags: drug shortages, patient care, adverse effects, patient outcomes
-
Sagent Pharmaceuticals Launches Octreotide Acetate Injection,a Somatostatin Analog
Dec 26, 2013Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 14, 2013US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 8, 2013US-based Sagent Pharmaceuticals (SGNT) has introduced an antineoplastic agent 'Carboplatin Injection' in four preservative-free vial presentations. The injection is indicated for the initial treatment of advanced ovarian carcinoma in ...
-
Galena Biopharma Has Launched The Abstral Sublingual Tablets in The US for Cancer Pain
Oct 8, 2013US-based biopharmaceutical company Galena Biopharma has launched the Abstral (fentanyl) sublingual tablets in the US for the treatment of breakthrough cancer pain. The sublingual (under the tongue) fentanyl tablet has been designed for ...
Tags: Sublingual Tablets, Medicine
-
SGNT Has Received The Approval of Zoledronic Acid Injection 4mg/100ml
Aug 9, 2013Sagent Pharma (SGNT) has received the approval of Zoledronic Acid Injection 4mg/100ml, the generic form of the bisphosphonate Zometa, to be packed in a ready-to-use premix IV bag. The new packaging for Zoledronic Acid Injection features ...
Tags: Sagent, Premix Bag, Zoledronic Acid
-
Sagent Has Re-Introduced an Antiarrhythmic Agent Amiodarone HCl Injection
Aug 7, 2013Sagent Pharmaceuticals has re-introduced an antiarrhythmic agent Amiodarone HCl Injection as an improved prefilled plastic syringe compatible with standard I.V. pumps. Featuring Sagent's PreventIV Measures packaging and labeling to help ...
Tags: HCL Injection, Health
-
Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Aug 2, 2013Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
-
Daiichi Sankyo Espha Has Launched Three New Generic Drugs
Jun 25, 2013Daiichi Sankyo Espha, Japan-based generics subsidiary of Daiichi Sankyo, has launched three new generic drugs, Pramipexole hydrochloride 0.125mg tablets DSEP, Pramipexole hydrochloride 0.5mg tablets DSEP and Amlodipine 10mg tablets DSEP, ...
-
Canada Rolled out Plain Language Labeling Initiative to Improve The Safe Use of Medicines
Jun 18, 2013Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all health care practitioners and Canadians. Canada health ...
Tags: Drug Safety, Labeling Initiative
-
FDA Has Granted 6 Months Pediatric Exclusivity for Hospira's Precedex Injection in The US
Mar 20, 2013The US Food and Drug Administration (FDA) has granted six months pediatric exclusivity for Hospira's Precedex (dexmedetomidine HCl) injection in the US. Precedex, an alpha-2 agonist, is approved for use only in adults and the US regulator ...
Tags: Hospira Precedex injection, Drug, FDA
Related Products
-
Syringe Pump Is Designed to Help Prevent IV Medication Administration Errors
-
Reduce Medication Errors and Increase Patient Safety Infusion Pump
-
Infusion Pump Proven to Reduce Medication Errors and Increase Patient Safety
-
Infusion Pump Is Redefining Smart Technology with Second Generation Software to Help Prevent Pump-Related Medication Errors
-
Infusion Pump Is Redefining Smart Technology with Second Generation Software to Help Prevent Pump-Related Medication Errors
